On November 30, 2017 the SIU Katowice team held a successful “The Brain in a Nutshell” event - amassing an interest in over 200 attendees. Understanding the brain is exceedingly important as it steers the very essence of life itself; and with this in mind, the SIU team welcomed three guest speakers to discuss current brain research and the vast possibilities that could come about from increasing our understanding of the brain.
Pneumonia affects hundreds of millions of people a year around the world and early detection of the disease is one of the most important preventative measures to bring the numbers down. CheXNet, a deep learning algorithm developed by scientists in Stanford, is one of the methods we can utilise machine learning for early detection of pneumonia.
Cell free fetal DNA (cffDNA) circulating in maternal blood was discovered back in 1997. It now shows promise in being used for non-invasive pre-natal screening to detect fetal chromosomal abnormalities and more. Read here for insights on the efficacy and advantages of this technique.
As part of our SIU Conference series, the Oxford division hosted three speakers at the ‘Neurotechnology and Applied Neuroscience’ event on 23rd November 2017 at Magdalen College, a primary sponsor of SIUOxford. Our speakers were selected based on their shared experience of utilising some aspect of applied neuroscience for social and/or commercial impact.
On November 20th in Frankfurt the SIU team welcomed Prof Gregory Wheeler and Prof Roberto V. Zicari to our SIUTranslations event to talk about Artificial Intelligence and its human side. Read on to find out what these experts discussed with our audience at this high-impact event.
The ongoing healthcare system crisis in Poland and the accompanying protests and hunger strikes that started recently concern the healthcare professionals in the country greatly. At our SIUConversations event that took place in Katowice on November 17 we addressed the questions and possible answers to the the problem with our three panellists.
On November 16, 2017, the London Division of the SIU organised a workshop with Dr Jeff Skinner, the Executive Director of the Institute of Innovation and Entrepreneurship at London Business School on commercial strategy. The main focus was on what it means to develop a commercial strategy for a researcher and if it is actually needed when the underlying technology is compelling enough to sell itself.
SIUOxford hosted our first educational event for this academic year on November 16th 2017, titled ‘Academia and Industry: Advancing Science and Your Career’. We welcomed three professionals, all with experience in both academia and industry, to share their career journeys and to offer advice to attendees on how to approach bridging the gap between the two areas.
Stroke is considered a pandemic because of the number of people affected every year around the world. Complications arising from methods traditionally used in treatment of blockage of arteries - an underlying cause - have led to the birth of TransCarotid Artery Revascularisation (TCAR) method. This article brings you all you want to know about this promising innovation.
On November 13, 2017, The Oxford Division of the SIU collaborated with Enterprising Oxford to host the CEO and co-founder of Labstep, Jake Schofield. The event was part of the #StartedinOxford series that highlights startups that were founded in the Oxford ecosystem. Here is the summary of the illuminating talk.
It is a common struggle for many aspiring scientists to gain knowledge and support to commercialise their scientific ideas. We interviewed Dr Jeff Skinner, the Executive Director of the Institute of Innovation and Entrepreneurship at London Business School (LBS).
We all find one way or another to enhance our daily performance. What is the biology behind the methods we use? How do these methods affect healthy versus unhealthy individuals? In this article we bring you all you need to know about neuroenhancement.
The SIU Translation series kicked off in Frankfurt on October 26 with the exciting topic of self-driving cars. Our speaker Peter Skvarenina, a specialist in advanced algorithms, machine learning and robotics, currently runs his own machine learning and automation company. Read on to find out about how a car can drive itself and what we can expect in the near future when it comes to transport.
We restarted our SIUConversations series with the new academic year in Katowice on October 12 and had a fantastic line-up of speakers to tell us about the latest in integration of Artificial Intelligence and robotics into healthcare and medicine. Here is the summary of the thought-provoking evening.
Integrating digital innovation into medicine is a very up-and-coming trend. Can we say the same when it comes to mental health? Here to tell us is Dr Samantha Scholtz, a consultant psychiatrist and R&D manager for the West London Mental Health Trust.
At their minuscule sizes of billionths of a metre, nanoparticles and their use in medicine brings about the field of nanomedicine, a field that carries a potential that is everything but minuscule. Read on to find out just what nanomedicine means and why it's of 'giga' importance.
From diagnosing diseases to growing organs in miniature environments to effective delivery of drugs to their targets, microfludics opens the door to a big world of potential in medicine. Read the last of our microfludics series to discover how the simple process of flowing liquids through microchannels can harbour an explosive innovative potential.
In this second article of the microfluidics series we talk about how the combination of life sciences research and engineering in the form of microfluidic devices can create wonders in the understanding and use of stem cells and their extraordinary properties.
Mimicking and understanding the environment molecules, cells and organs work in requires creative thinking and sublime engineering. Microfluidics technology is a product of such a process and makes it possible for researchers to achieve results that cannot be achieved by other means. Read the first instalment of our new 3-part series on microfluidics here to see what we mean.
The promising developments in immunotherapy in recent years catch the attention of not only patients and researchers but also investors. In this article we bring you the latest financial trends in immunotherapy investments.